Ocugen Inc. (NASDAQ:OCGN) is one of the 10 best penny stocks that could triple your money. On March 24, Ocugen Inc. (NASDAQ:OCGN) announced 12-month data from the Phase 2 ArMaDa clinical trial ...
Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for serious and rare diseases, today ...
A new class of weight loss drug just took a major step toward approval for use. In a phase III clinical trial, medication ...
Clinical trials are losing participants. Patient-first design and decentralized models can help fix the dropout problem.
GlobalData on MSN
Trials to watch: Phase III TB vaccines and MDR-TB treatments
GlobalData epidemiologists project TB cases across the 16 major markets to reach 4.5 million by 2033.
MedPage Today on MSN
Are Bayesian Statistics Coming to a Clinical Trial Near You?
What physicians should know about FDA's new proposed guidance ...
YouTube on MSNOpinion
'That's terrible' - What statin trials really show
In this letter, we examine not one but three meta-analyses of randomized controlled trials to explore a provocative question: ...
U.S. Food and Drug Administration (FDA) guidance states that payment for participation in clinical trials must be just, fair, and receive approval from an institutional review board (IRB). According ...
City of Hope, which earlier this month opened a new hospital in Orange County, Calif., (shown in this picture) now has a network of five specialized cancer hospitals across the country and 38 clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results